Issue #30

Issue #30

December 15, 2022

December 15, 2022 | Issue #30

Good Evening

. Welcome back to another issue of Spannr.

In this week's newsletter

:

šŸ„ An intro to Longevity Clinics

šŸ“¢ Business + Funding news 

šŸ“š Longevity-related good reads from around the web

The Future Of Healthcare Clinics

Longevity clinics are becoming increasingly popular as people strive to stay healthy for as long as possible.These health providers focus on the early detection and treatment of diseases that are age-dependent, and the prolongation of the active phase of a personā€™s life, in which mental, physical, and social activities are preserved.Ultimately, these clinics represent a new and emerging direction in healthcare that aims to increase the average life expectancy of patients.In our latest article, we examine the new services offered by the most cutting-edge longevity clinics worldwide and observe what clinical technologies are on the horizon.

  • BiomeBank, a clinical stage biotechnology company developing a pipeline of microbiome-based therapies to treat unmet medical need, completes a $10 million capital raise with participation from Ellerston Capital, South Australian Venture Capital Fund, and the Hospital Research Foundation

  • Sonde Health, a leader in voice-based health monitoring, raises $19.25 million Series B led by Partners Investment, with participation from NEOM Company and KT Corporation

  • Vevo Therapeutics, a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients, launches with oversubscribed $12 million seed financing co-led by Wing Venture Capital and General Catalyst

  • Apogee Therapeutics, a biotechnology company advancing novel therapies to address the needs of the millions of people living with immunological and inflammatory disorders, announced the closing of a $149 million Series B financing co-led by Deep Track Capital and RTW Investments

  • NewLimit Provides November 2022 Progress Update

  • AthenaDAO, a decentralized collective to fund womenā€™s reproductive health research, launched its new branding and website in combination with its inaugural "Reproductive Health Report"

  • Catalent opens cell therapy production site at Belgian 'center of excellence'

  • Sirona Biochem Announces Start of Clinical Trial for Anti-Aging Compound TFC-1326

  • Pfizer just made history by becoming the first pharmaceutical company to vote on a DAO proposal (VitaDAO)

  • David Sinclair's thoughts and reflections on the FDA's decision to ban NMN dietary supplements (David Sinclair)

  • Vaccine extends life for patients with brain cancer (Futurity)

  • Modernaā€™s mRNA Cancer Vaccine Shows Promise in Preliminary Study (WSJ)

  • An Interview with Mark Hamalainen: Longevity Biotech Fellowship, Getting involved, Retreat, David Sinclair & more (Learning with Lowell)

  • Base editing: Revolutionary therapy clears girl's incurable cancer (BBC)

  • The secret to adding ā€˜an extra 10 good yearsā€™ to your life could be eating like you live in a blue zone. Hereā€™s how to start (Fortune)

  • The first study to measure Vitamin D in the brain could help reveal how to maintain cognitive health (INVERSE)

  • Young plasma transfer recovers decreased sperm counts and restores epigenetics in aged testis (Elsevier BV)

Performance:

Latest Price: $117.767d-Return: -3.82% Market Cap: $10.03b

Big Movers:

Brainstorm Cell (BCLI): 24.83%Humacyte (HUMA): -15.31%Miromatix (MIRO): -30.07%